Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07363720 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

StatusActive, Not Recruiting
PhasePhase 3
SponsorTakeda
Started2026-01-29
View on ClinicalTrials.gov ↗
The main aim of this study is to assess how effective TAK-861 is for treating narcolepsy type 1 and if this effect is maintained over time. Participants will take TAK-861 for a few months and if they meet certain criteria, they will be randomly assigned (by chance, like flipping a coin) to continue taking TAK-861 or take placebo (fake medicine) for up to 4 weeks to see if their narcolepsy symptoms return.

Amendment history 4 changes detected by DataLookout

2026-09-02
Enrollment closed, study ongoing
2026-09-02
Final enrollment: 98 participants (planned 88)
2026-07-09
Trial sites expanded: 18 → 25 locations
2026-05-09
Trial sites expanded: 7 → 18 locations
Trial Details
NCT Number NCT07363720
Lead Sponsor Takeda
Conditions Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy
Enrollment 98 participants
Start Date 2026-01-29
Primary Completion 2026-10-02 (estimated)
Study Completion 2026-10-02 (estimated)
Updated on ClinicalTrials.gov 2026-09-01